MGM vs PLX · P/E 64, rev $4.45B vs P/E 31, rev $53.6M
MGM Resorts International (MGM) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
MGM currently screens at market cap $12.01B and trailing P/E 64.3. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the MGM and PLX stock pages for the full models.
Not investment advice.